CILOSTAZOL AMELIORATES METABOLIC ABNORMALITIES IN A DB/DB MOUSE MODEL OF TYPE 2 DIABETES VIA ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORγ TRANSCRIPTION

被引：1
|
作者：
Park, S. Y.
Hong, K. W.
Lee, W. S.
Kim, C. D.
机构：
[1] Med Res Ctr Ischem Tissue Regenerat, Gyeongnam, South Korea
[2] Pusan Natl Univ, Dept Pharmacol, Gyeongnam, South Korea
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70080-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P13
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Cilostazol Ameliorates Metabolic Abnormalities with Suppression of Proinflammatory Markers in a db/db Mouse Model of Type 2 Diabetes via Activation of Peroxisome Proliferator-Activated Receptor γ Transcription
    Park, So Youn
    Shin, Hwa Kyoung
    Lee, Jeong Hyun
    Kim, Chi Dae
    Lee, Won Suk
    Rhim, Byung Yong
    Hong, Ki Whan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (02): : 571 - 579
  • [2] Muraglitazar, a novel dual (α/γ) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves β-cell function in db/db mice
    Harrity, T
    Farrelly, D
    Tieman, A
    Chu, CX
    Kunselman, L
    Gu, LQ
    Ponticiello, R
    Cap, M
    Qu, FC
    Shao, CN
    Wang, W
    Zhang, H
    Fenderson, W
    Chen, S
    Devasthale, P
    Jeon, Y
    Seethala, R
    Yang, WP
    Ren, J
    Zhou, M
    Ryono, D
    Biller, S
    Mookhtiar, KA
    Wetterau, J
    Gregg, R
    Cheng, PT
    Hariharan, N
    DIABETES, 2006, 55 (01) : 240 - 248
  • [3] The dual peroxisome proliferator-activated receptor α/γ activator muraglitazar prevents the natural progression of diabetes in db/db mice
    Tozzo, Effie
    Ponticiello, Randolph
    Swartz, JoAnn
    Farrelly, Dennis
    Zebo, Rachel
    Welzel, Gustav
    Egan, Donald
    Kunselman, Lori
    Peters, Andrew
    Gu, Liqun
    French, Michele
    Chen, Sean
    Devasthale, Pratik
    Janovitz, Evan
    Staal, Ada
    Harrity, Thomas
    Belder, Rene
    Cheng, Peter T.
    Whaley, Jean
    Taylor, Simeon
    Hariharan, Narayanan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (01): : 107 - 115
  • [4] Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-γ activation in +db/+m and +db/+db mice
    Seto, Sai Wang
    Lam, Tsz Yan
    Leung, George P. H.
    Au, Alice L. S.
    Ngai, Sal Ming
    Chan, Shun Wan
    Kwan, Yiu Wa
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 572 (01) : 40 - 48
  • [5] Inhibition of Aldose Reductase Activates Hepatic Peroxisome Proliferator-Activated Receptor-α and Ameliorates Hepatosteatosis in Diabetic db/db Mice
    Qiu, Longxin
    Lin, Jianhui
    Xu, Fangui
    Gao, Yuehong
    Zhang, Cuilin
    Liu, Ying
    Luo, Yu
    Yang, James Y.
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [6] Peroxisome proliferator-activated receptor α/γ dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice
    Cha, Dae Ryong
    Zhang, Xiaoyan
    Zhang, Yahua
    Wu, Jing
    Su, Dongming
    Han, Jee Young
    Fang, Xuefen
    Yu, Bo
    Breyer, Matthew D.
    Guan, Youfei
    DIABETES, 2007, 56 (08) : 2036 - 2045
  • [7] Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome
    Miller, AR
    Etgen, GJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (09) : 1489 - 1500
  • [8] Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Jay, Mollie A.
    Ren, Jun
    CURRENT DIABETES REVIEWS, 2007, 3 (01) : 33 - 39
  • [9] A nonthiazolidinedione peroxisome proliferator-activated receptor γ agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice
    Howarth, AG
    Wiehler, WB
    Pannirselvam, M
    Jiang, YF
    Berger, JP
    Severson, D
    Anderson, TJ
    Triggle, CR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01): : 364 - 370
  • [10] Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes
    Blaschke, F
    Takata, Y
    Caglayan, E
    Law, RE
    Hsueh, WA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (01) : 28 - 40
12345